GASTROINTESTINAL STROMAL NEOPLASMS

Clinical trials for GASTROINTESTINAL STROMAL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new GASTROINTESTINAL STROMAL NEOPLASMS trials appear

Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for GIST patients: could velzatinib outperform standard care?

Disease control Not yet recruiting

This study compares a new drug, velzatinib, to the current standard treatment imatinib in people with advanced GIST that has spread or cannot be removed by surgery. About 800 adults who have not had prior treatment for advanced GIST will be randomly assigned to receive either vel…

Matched conditions: GASTROINTESTINAL STROMAL NEOPLASMS

Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

GASTROINTESTINAL STROMAL NEOPLASMS

Get alerted when new GASTROINTESTINAL STROMAL NEOPLASMS trials appear

New hope for GIST patients: could velzatinib outperform standard care?